These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 12798886

  • 1. A randomized, placebo-controlled, dose-ranging trial comparing fulvestrant with goserelin in premenopausal patients with uterine fibroids awaiting hysterectomy.
    Donnez J, Hervais Vivancos B, Kudela M, Audebert A, Jadoul P.
    Fertil Steril; 2003 Jun; 79(6):1380-9. PubMed ID: 12798886
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
    Stewart EA, Diamond MP, Williams ARW, Carr BR, Myers ER, Feldman RA, Elger W, Mattia-Goldberg C, Schwefel BM, Chwalisz K.
    Hum Reprod; 2019 Apr 01; 34(4):623-634. PubMed ID: 30865281
    [Abstract] [Full Text] [Related]

  • 3. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
    Muneyyirci-Delale O, Richard-Davis G, Morris T, Armstrong J.
    Clin Ther; 2007 Aug 01; 29(8):1682-91. PubMed ID: 17919549
    [Abstract] [Full Text] [Related]

  • 4. Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results.
    Loibl S, Turner NC, Ro J, Cristofanilli M, Iwata H, Im SA, Masuda N, Loi S, André F, Harbeck N, Verma S, Folkerd E, Puyana Theall K, Hoffman J, Zhang K, Bartlett CH, Dowsett M.
    Oncologist; 2017 Sep 01; 22(9):1028-1038. PubMed ID: 28652278
    [Abstract] [Full Text] [Related]

  • 5. Treatment with the gonadotrophin releasing hormone-agonist goserelin before hysterectomy for uterine fibroids.
    Lumsden MA, West CP, Thomas E, Coutts J, Hillier H, Thomas N, Baird DT.
    Br J Obstet Gynaecol; 1994 May 01; 101(5):438-42. PubMed ID: 8018618
    [Abstract] [Full Text] [Related]

  • 6. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A, Vollenhoven B, Sowter M.
    Cochrane Database Syst Rev; 2001 May 01; (2):CD000547. PubMed ID: 11405968
    [Abstract] [Full Text] [Related]

  • 7. Total and unbound cytosolic estrogen and progesterone receptors in myometrium and fibroid after gonadotropin-releasing hormone agonist treatment.
    Fernández-Montolí ME, Díez-Gibert O, Samaniego JM, Balagueró L, Navarro MA.
    Fertil Steril; 1995 Mar 01; 63(3):522-7. PubMed ID: 7851581
    [Abstract] [Full Text] [Related]

  • 8. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A, Vollenhoven B, Sowter M.
    Cochrane Database Syst Rev; 2000 Mar 01; (2):CD000547. PubMed ID: 10796723
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of tibolone as "add-back therapy" in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids.
    Morris EP, Rymer J, Robinson J, Fogelman I.
    Fertil Steril; 2008 Feb 01; 89(2):421-8. PubMed ID: 17572410
    [Abstract] [Full Text] [Related]

  • 10. Goserelin acetate to avoid hysterectomy in pre-menopausal women with fibroids requiring surgery.
    Parazzini F, Bortolotti A, Chiantera V, Scollo P, Del Monaco D, Bianchi M, Bennici S.
    Eur J Obstet Gynecol Reprod Biol; 1999 Nov 01; 87(1):31-3. PubMed ID: 10579613
    [Abstract] [Full Text] [Related]

  • 11. Fibroid management in premenopausal women.
    Donnez J, Courtoy GE, Dolmans MM.
    Climacteric; 2019 Feb 01; 22(1):27-33. PubMed ID: 30601065
    [Abstract] [Full Text] [Related]

  • 12. Zoladex (goserelin acetate) and the anemic patient: results of a multicenter fibroid study.
    Benagiano G, Kivinen ST, Fadini R, Cronjé H, Klintorp S, van der Spuy ZM.
    Fertil Steril; 1996 Aug 01; 66(2):223-9. PubMed ID: 8690106
    [Abstract] [Full Text] [Related]

  • 13. Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer.
    Bartsch R, Bago-Horvath Z, Berghoff A, DeVries C, Pluschnig U, Dubsky P, Rudas M, Mader RM, Rottenfusser A, Fitzal F, Gnant M, Zielinski CC, Steger GG.
    Eur J Cancer; 2012 Sep 01; 48(13):1932-8. PubMed ID: 22459763
    [Abstract] [Full Text] [Related]

  • 14. Goserelin versus leuprolide before hysterectomy for uterine fibroids.
    Lim SS, Sockalingam JK, Tan PC.
    Int J Gynaecol Obstet; 2008 May 01; 101(2):178-83. PubMed ID: 18164303
    [Abstract] [Full Text] [Related]

  • 15. An evidence-based approach to hormonal therapies for premenopausal women with fibroids.
    Lethaby AE, Vollenhoven BJ.
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr 01; 22(2):307-31. PubMed ID: 17905660
    [Abstract] [Full Text] [Related]

  • 16. Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.
    Barlow DH, Lumsden MA, Fauser BC, Terrill P, Bestel E.
    Hum Reprod; 2014 Mar 01; 29(3):480-9. PubMed ID: 24457604
    [Abstract] [Full Text] [Related]

  • 17. Fulvestrant treatment is associated with cholesterol plasma level reduction in hormone-receptor-positive metastatic breast cancer patients.
    Camerini A, Rondini M, Garrone O, Valsuani C, Donati S, Siclari O, Sgambato A, Tartarelli G, Vincenti M, Mattiot VP, Porta RP, Puccetti C, Puccinelli P, Amoroso D.
    Cancer Biol Ther; 2009 Aug 01; 8(15):1450-5. PubMed ID: 19556864
    [Abstract] [Full Text] [Related]

  • 18. Shrinkage of uterine fibroids by preoperative LHRH analogue injection.
    McClelland HR, Quinn AJ.
    Ulster Med J; 1992 Apr 01; 61(1):51-5. PubMed ID: 1535743
    [Abstract] [Full Text] [Related]

  • 19. Gonadotropin releasing hormone agonist treatment before hysterectomy for menorrhagia and uterine leiomyomas.
    Vercellini P, Bocciolone L, Colombo A, Vendola N, Meschia M, Bolis G.
    Acta Obstet Gynecol Scand; 1993 Jul 01; 72(5):369-73. PubMed ID: 8392268
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.